Capstone Holding Corp. (CAPS)
NASDAQ: CAPSHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Nov 20, 4:00 PM ET · Delayed 15 min
CAPS stock chart
Technical analysisKey statistics
All statistics- Market cap
- $1.35M
- EPS (TTM)
- -$89.68
- Dividend yield
- None
- 52-week range
- 1.42 – 28.50
- Day range
- 1.42 – 1.54
- Volume / Avg
- 21.11K / 153.70K
- Beta
- —
- Shares outstanding
- 935.38K
52-week range
CAPS stock today
On Nov 20, CAPS ended the session at $1.44, shedding $0.145 (9.15%), versus the S&P 500's 3.70% decline. Trading was light, with 21.11K shares changing hands, about 14% of the average daily volume. Shares are 94.9% below their 52-week high of $28.50 and 1.8% above the 52-week low of $1.42, near the bottom of the past year's range.
Capstone has posted a net loss over the last twelve months (EPS of -$89.68), so its P/E ratio is not meaningful.
Summary generated from market data by MetaCap's automated system. Methodology
About Capstone
Company profileCapstone Holding Corp., through its subsidiaries, engages in the distribution and installation of building products in the United States and Canada. It operates in two segments, TotalStone and Carolina Stone. The company offers manufactured stone veneer under the Cultured Stone, Dutch Quality Stone, and Toro Stone brand names; natural stone under the Pangaea Stone brand name; panelized stone system under the Interloc brand name; mechanically attached stone veneer systems under the Beon Stone brand name; moisture management system under the D-Rain brand name; landscape and hardscape products under the Aura Natural Landscapes brand name; and modular masonry fireplaces under the Isokern brand name.
- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- CEO
- Mr. Matthew E. Lipman
- Headquarters
- Alsip, IL
- Employees
- 93
- Website
- capstoneholdingcorp.com
Financial highlights
Full financialsIn fiscal 2025, Capstone generated $46.9 million in revenue, up 4.5% from fiscal 2024. Capstone reported a net loss of $21.2 million, compared with a loss of $2.6 million a year earlier. Gross margin was 23.0% (up from 21.3%) and operating margin -23.4%.
| Fiscal year | FY 2025 | FY 2024 | FY 2023 | FY 2018 | FY 2017 |
|---|---|---|---|---|---|
| Revenue | $46.88M | $44.88M | $48.35M | $-2.00M | $0 |
| Growth | +4.47% | -7.19% | +2517.70% | — | — |
| Net income | $-21.23M | $-2.56M | $-3.82M | $380.00K | $1.75M |
| EPS (diluted) | — | $-34.87 | $-36.39 | $-0.01 | $-0.04 |
Analyst forecast
ForecastConsensus (1 analysts)
none
Avg. price target
$3.00+108.33%
- Strong buy 0
- Buy 1
- Hold 0
- Sell 0
- Strong sell 0
Ratings and targets reflect third-party analyst opinions, not MetaCap recommendations.
Earnings
Earnings history- Last reported (Sep/2026)
- Nov 17, 2026
- EPS actual vs est.
- $-1.28 vs —
CAPS news
All CAPS news- Capstone Holding Corp. Reports Q3 2026 Revenue Growth of 46% and Revises Full-Year GuidanceNasdaq
- Capstone Reports Q3 2026 Results: Revenue Up 46% to $20.0 Million, Gross Profit Up 76%, Operating Income of $0.4 MillionBusiness Wire
- Capstone Holding Corp. Amends Senior Secured Convertible Note and Common Stock Purchase AgreementNasdaq
- Capstone Holding Corp. Announces 1-for-30 Reverse Stock SplitNasdaq
Capstone peers
Health Care sector| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| CMNDClearmind Medicine Inc. | 2.63 | -17.68% | $1.33M | vs CAPS |
| ELABPMGC Holdings Inc. | 1.14 | -10.24% | $1.33M | vs CAPS |
| ARTLArtelo Biosciences Inc. | 1.39 | -4.14% | $1.30M | vs CAPS |
| APVOAptevo Therapeutics Inc. | 0.4041 | -2.37% | $1.40M | vs CAPS |
| JUNSJupiter Neurosciences Inc. | 1.24 | -18.75% | $1.63M | vs CAPS |
| PRFXPRF Technologies Ltd. | 0.4758 | -23.68% | $1.66M | vs CAPS |
| GOVXGeoVax Labs Inc. | 1.81 | -5.24% | $985.46K | vs CAPS |
| BDRXBiodexa Pharmaceuticals plc American Depositary Shs | 1.88 | -3.85% | $982.95K | vs CAPS |
Indexes, lists and sector
Capstone stock FAQ
What is Capstone's stock price today?
CAPS last traded at $1.44 as of Nov 20, 4:00 PM EST, down 9.15% on the day. Prices are delayed at least 15 minutes.
Does Capstone pay a dividend?
No. Capstone does not currently pay a regular cash dividend.
Who is Capstone's CEO?
Mr. Matthew E. Lipman is the chief executive officer of Capstone Holding Corp., which has about 93 employees.
Has CAPS ever split its stock?
Yes. The most recent CAPS stock split was a 1-for-30 split on Oct 19, 2026.
What is the CAPS 52-week high?
The 52-week high for CAPS is $28.50 and the 52-week low is $1.42. The stock is currently 94.9% below its high.